pemoline has been researched along with fluoxetine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jerome, L | 1 |
| Metz, A; Shader, RI | 1 |
| Dogin, JW; Findling, RL | 1 |
| Berry, I; Boulanouar, K; Carel, C; Celsis, P; Chollet, F; Loubinoux, I; Ranjeva, JP; Rascol, O | 1 |
| Castaneda, R; Hardy, M; Levy, R; Trujillo, M | 1 |
| Balon, R; Doll, RG; Jayaraman, A; Pohl, R; Yeragani, V | 1 |
2 review(s) available for pemoline and fluoxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
1 trial(s) available for pemoline and fluoxetine
| Article | Year |
|---|---|
Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans.
Topics: Adult; Anxiety Disorders; Cardiac Output; Central Nervous System Stimulants; Death, Sudden, Cardiac; Depressive Disorder; Electroencephalography; Female; Fluoxetine; Heart Rate; Humans; Male; Pemoline; Placebos; Selective Serotonin Reuptake Inhibitors | 2003 |
10 other study(ies) available for pemoline and fluoxetine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacotherapy of eating and behavioral problems.
Topics: Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Male; Methylphenidate; Pemoline; Prader-Willi Syndrome | 1991 |
Combination of fluoxetine with pemoline in the treatment of major depressive disorder.
Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Pemoline | 1991 |
Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks.
Topics: Adult; Brain; Brain Mapping; Central Nervous System Stimulants; Cerebellum; Female; Fluoxetine; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Pemoline; Psychomotor Performance | 1999 |
Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Topics: Adult; Algorithms; Amphetamines; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Delayed-Action Preparations; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Fluoxetine; Humans; Methylphenidate; Outcome Assessment, Health Care; Pemoline | 2000 |